Cargando…
CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan
OBJECTIVE: Loss of caudal-type homeobox transcription factor 2 (CDX2) expression in colorectal cancers (CRCs) has recently been proposed as a promising predictive biomarker for not only prognosis but also response to chemotherapy. However, the relationship between alterations in CDX2 expression duri...
Autores principales: | Shigematsu, Yasuyuki, Inamura, Kentaro, Mise, Yoshihiro, Saiura, Akio, Rehnberg, Emil, Yamamoto, Noriko, Ishikawa, Yuichi, Takahashi, Shunji, Kanda, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908305/ https://www.ncbi.nlm.nih.gov/pubmed/29682204 http://dx.doi.org/10.18632/oncotarget.24842 |
Ejemplares similares
-
Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis
por: Shigematsu, Yasuyuki, et al.
Publicado: (2018) -
CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses
por: Sugawara, Emiko, et al.
Publicado: (2023) -
Multidisciplinary treatment for colorectal liver metastases in elderly patients
por: Hata, Taigo, et al.
Publicado: (2020) -
Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liver: Clinical and pathological features
por: Shigematsu, Yasuyuki, et al.
Publicado: (2022) -
Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
por: Inamura, Kentaro, et al.
Publicado: (2018)